Predicting cetuximab accumulation in KRAS wild-type and KRAS mutant colorectal cancer using 64Cu-labeled cetuximab positron emission tomography

Colon Cancer

(2017) Paul F. Engstrom et al.   Journal of the National Comprehensive Cancer Network

Oncogenic KRAS Desensitizes Colorectal Tumor Cells to Epidermal Growth Factor Receptor Inhibition and Activation

(2015) Winan J. van Houdt et al.   NEOPLASIA

Systematic Review: Anti–Epidermal Growth Factor Receptor Treatment Effect Modification byKRASMutations in Advanced Colorectal Cancer

(2013) Issa J. Dahabreh et al.   ANNALS OF INTERNAL MEDICINE

Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment

(2010) E. Van Cutsem et al.   ANNALS OF ONCOLOGY

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Imaging and biodistribution of Her2/neu expression in non-small cell lung cancer xenografts with 64Cu-labeled trastuzumab PET

(2010) Pramila Paudyal et al.   CANCER SCIENCE

Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts

(2010) Bishnuhari Paudyal et al.   CANCER SCIENCE

PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-A″-DTPA-cetuximab

(2010) Tapan K. Nayak et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Epidermal growth factor receptor gene copy number in 101 advanced colorectal cancer patients treated with chemotherapy plus cetuximab

(2010) Carla Campanella et al.   Journal of Translational Medicine

Colorectal cancer: cetuximab,KRAS,BRAF,PIK3CAmutations and beyond

(2010) Christos Katsios et al.   Expert Review of Gastroenterology & Hepatology

Molecular Imaging of Cancer with Copper-64 Radiopharmaceuticals and Positron Emission Tomography (PET)

(2009) Monica Shokeen et al.   ACCOUNTS OF CHEMICAL RESEARCH

Cetuximab-based therapy versus non-cetuximab therapy for advanced cancer: a meta-analysis of 17 randomized controlled trials

(2009) Lidan Liu et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

In Vivo Molecular Imaging of Colorectal Cancer With Confocal Endomicroscopy by Targeting Epidermal Growth Factor Receptor

(2009) Martin Goetz et al.   GASTROENTEROLOGY

Usefulness of Peptide Nucleic Acid (PNA)-Clamp Smart Amplification Process Version 2 (SmartAmp2) for Clinical Diagnosis of KRAS Codon12 Mutations in Lung Adenocarcinoma

(2009) Takuya Araki et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Radiation Dosimetry of 89Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients

(2009) P. K.E. Borjesson et al.   JOURNAL OF NUCLEAR MEDICINE

PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma Models

(2009) G. Niu et al.   JOURNAL OF NUCLEAR MEDICINE

Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

(2009) Eric Van Cutsem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Receptor-Binding, Biodistribution, and Metabolism Studies of 64Cu-DOTA-Cetuximab, a PET-Imaging Agent for Epidermal Growth-Factor Receptor-Positive Tumors

(2008) Wen Ping Li et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Cetuximab: Preclinical Evaluation of a Monoclonal Antibody Targeting EGFR for Radioimmunodiagnostic and Radioimmunotherapeutic Applications

(2008) Diane E. Milenic et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Molecular Imaging of Therapeutic Response to Epidermal Growth Factor Receptor Blockade in Colorectal Cancer

(2008) H. C. Manning et al.   CLINICAL CANCER RESEARCH

Imaging of EGFR and EGFR Tyrosine Kinase Overexpression in Tumors by Nuclear Medicine Modalities

(2008) Eyal Mishani et al.   CURRENT PHARMACEUTICAL DESIGN

Correlating EGFR Expression with Receptor-Binding Properties and Internalization of 64Cu-DOTA-Cetuximab in 5 Cervical Cancer Cell Lines

(2008) M. Eiblmaier et al.   JOURNAL OF NUCLEAR MEDICINE

Disparity Between In Vivo EGFR Expression and 89Zr-Labeled Cetuximab Uptake Assessed with PET

(2008) H. J.W.L. Aerts et al.   JOURNAL OF NUCLEAR MEDICINE

EGFR Antagonists in Cancer Treatment

(2008) Fortunato Ciardiello et al.   NEW ENGLAND JOURNAL OF MEDICINE